Progress in research, clinical trials of domestic COVID-19 vaccines updated
The Ministry of Health (MoH) has reported on the domestic production of vaccines against the COVID-19, and the receipt and immunisation of vaccines to the Prime Minister.
Progress in research, clinical trials of domestic COVID-19 vaccines updated. - Illustrative image (Photo: VNA)
Hanoi (VNA) - The Ministry of Health (MoH) has reported on the domestic production of vaccines against the COVID-19, and the receipt and immunisation of vaccines to the Prime Minister.
There are five vaccines being in the research and clinical trial process, namely Nanocovax, COVIVAC, ARCT-154, COVID-19 HIPRA and S – 268019, the ministry said, adding the research is being conducted on schedule and in line with contents of the research plans approved by the ministry. The work is expected to complete in December next year.
As of August 11, Vietnam received 253,071,094 doses of COVID-19 vaccine, including 234,636,494 for the people aged 12 and above, and 18,434,600 for children aged between 5-11.
Ilustrative image (Photo: VNA)
So far, as many as 249,778,892 doses have been administered to people nationwide, with 100% of people aged over 18 years old; and from 12 to under 18 getting the first and second injections.
The vaccination rate of 3rd and 4th shots in the over-18-year-old group reached 73.9% and 57.4%, respectively.
In July, as many as 13.4 million doses of COVID-19 vaccine were administered to people nationwide, up 2.1 million compared to June, the ministry said.
Localities across the country are swiftly deploying the vaccination of the 1st and 2nd shot for children aged 5 - under 12; the third shot for people aged 12 and older; and the fourth shots for the groups that are designated under the guidance of the Ministry of Health./.
The Ministry of Health (MoH) has demanded units and localities nationwide to swiftly deploy the injection of the 3rd shots of COVID-19 vaccines for children aged 12-17.
More than 40 million people nationwide had held COVID-19 vaccine passports as of July 20, according to the Ministry of Health’s Electronic Health Administration.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Progress in research, clinical trials of domestic COVID-19 vaccines updated. - Illustrative image (Photo: VNA) 
Ilustrative image (Photo: VNA) 
